The Role of Inhalatory Corticosteroids and Long Acting β2 Agonists in the Treatment of Patients Admitted to Hospital Due to Acute Exacerbations of Chronic Obstructive Pulmonary Disease (Aecopd)

The Role of Inhalatory Corticosteroids and Long Acting β2 Agonists in the Treatment of Patients Admitted to Hospital Due to Acute Exacerbations of Chronic Obstructive Pulmonary Disease (Aecopd)

There is the question about the role of fixed combination of inhalatory corticosteroids and long acting β2 agonists in the treatment of patients admitted in hospital due to AECOPD. The objective of this study is to determine the frequency of etiologic factors of AECOPD, to research the length of rec...

Full description

Bibliographic Details
Main Author:	Bakir Mehić
Format:	Article
Language:	English
Published:	Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2007-11-01
Series:	Bosnian Journal of Basic Medical Sciences
Subjects:	inhalatory corticosteroids long acting β2 agonists Acute Exacerbations of Chronic Obstructive Pulmonary Disease treatment
Online Access:	http://www.bjbms.org/ojs/index.php/bjbms/article/view/3026

Similar Items

Real-Life Patterns of Exacerbations While on Inhaled Corticosteroids and Long-Acting Beta Agonists for Asthma over 15 Years
by: Michael J. McGeachie, et al.
Published: (2020-03-01)

Exacerbations in COPD patients treated with Inhaled Corticosteroids/Long-acting β2 agonists combinations, switching to another combination drugs or inhaler device: A “real – world” study
by: Diego Sangiorgi, et al.
Published: (2017-01-01)

Compare the Effect of Inhaled Corticosteroids and Systemic Corticosteroids on Sputum Microbiome of AECOPD
by: Nan Ma, et al.
Published: (2021-02-01)

Management of chronic obstructive pulmonary disease: Insights into patient profile – Use of inhaled corticosteroids/long-acting β2-Agonists or long-acting β2-agonists/long-acting muscarinic antagonists
by: Nevin Kishore, et al.
Published: (2020-01-01)

Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β2-agonist via dry-powder inhalers and pressurized metered-dose inhalers
by: Wittbrodt ET, et al.
Published: (2018-12-01)

Association Between Statin Use and Exacerbation of Chronic Obstructive Pulmonary Disease Among Patients Receiving Corticosteroids
by: Huang YJ, et al.
Published: (2021-03-01)

Ultra Long-Acting β-Agonists in Chronic Obstructive Pulmonary Disease
by: Burkes RM, et al.
Published: (2020-12-01)

Corticosteroid plus β2-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis
by: Gang Wang, et al.
Published: (2017-12-01)

Nebulized corticosteroids in the management of acute exacerbation of COPD
by: Gaude G, et al.
Published: (2010-01-01)

Assessment of high-dose inhalational corticosteroids vs systemic corticosteroids in acute exacerbations of COPD in diabetic patients
by: A. S. Magdy, et al.
Published: (2020-01-01)

Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)? CON
by: Pedro J Marcos, et al.
Published: (2018-06-01)

Comparison of the Clinical Outcomes Between Nebulized and Systemic Corticosteroids in the Treatment of Acute Exacerbation of COPD in China (CONTAIN Study): A Post Hoc Analysis
by: Chen Y, et al.
Published: (2020-09-01)

The effect of adding long acting beta 2 agonists to inhaled corticosteroids versus increasing dose of inhaled corticosteroids in improving asthma control
by: Nisreen M. Nabil, et al.
Published: (2014-10-01)

A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease
by: Marc Miravitlles, et al.
Published: (2017-11-01)

Real-world antibiotic use in treating acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in China: Evidence from the ACURE study
by: Yiming Ma, et al.
Published: (2021-05-01)

Impulse Oscillometry; Therapeutic Impacts of Transdermal Long-Acting Beta-2 Agonist Patch in Elderly Asthma with Inhaled Corticosteroid Alone
by: Hiroshi Tanaka, et al.
Published: (2012-01-01)

Adjuvant Inhaled Corticosteroids in Community-Acquired Pneumonia: A Review Article
by: Faeq R. Kukhon, et al.
Published: (2021-05-01)

Non-adherence to inhaled corticosteroids and the risk of asthma exacerbations in children
by: Vasbinder EC, et al.
Published: (2016-04-01)

Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting
by: Perrone V, et al.
Published: (2016-11-01)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
by: Vestbo J, et al.
Published: (2019-04-01)

Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT
by: Graham Devereux, et al.
Published: (2019-07-01)

Pre-hospital use of inhaled corticosteroids and inhaled beta agonists and incidence of ARDS: A population-based study
by: Asif Muhammad Mangi, et al.
Published: (2015-11-01)

Maintenance therapy in COPD: time to phase out ICS and switch to the new LAMA/LABA inhalers?
by: Tariq SM, et al.
Published: (2017-06-01)

Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma
by: Richard Beasley, et al.
Published: (2019-12-01)

A randomized, open labeled, comparative study to assess the efficacy and safety of controller medications as add on to inhaled corticosteroid and long-acting β2 agonist in the treatment of moderate-to-severe persistent asthma
by: Patel Y, et al.
Published: (2010-01-01)

Do Benefits Outweigh Risks for Corticosteroid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease in People with Diabetes Mellitus?
by: Aldibbiat AM, et al.
Published: (2020-03-01)

Inflammation and infections in unreported chronic obstructive pulmonary disease exacerbations
by: Calderazzo MA, et al.
Published: (2019-04-01)

Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial)
by: Pascal Urwyler, et al.
Published: (2019-12-01)

Factors affecting the timing of systemic corticosteroid administration in acute asthma exacerbations in an urban pediatric emergency department
by: Johnson, Laurie
Published: (2013)

Effects of inspired oxygen fractions in rabbits anesthetized with isoflurane or sevoflurane, maintained on spontaneous ventilation
by: M. Horr, et al.

Treatment after a COPD exacerbation
by: Robbins RA
Published: (2013-07-01)

Effect of sequential treatment with syndrome differentiation on acute exacerbation of chronic obstructive pulmonary disease and "AECOPD Risk-Window": study protocol for a randomized placebo-controlled trial
by: Haifeng Wang, et al.
Published: (2012-04-01)

Prolonged stay predictors in patients admitted with chronic obstructive pulmonary disease acute exacerbation
by: María-Teresa García-Sanz, et al.
Published: (2018-01-01)

Which inhaled corticosteroid and long-acting β-agonist combination is better in patients with moderate-to-severe asthma, a dry powder inhaler or a pressurized metered-dose inhaler?
by: Masato Muraki, et al.
Published: (2017-01-01)

Glucocorticosteroids in the treatment of exacerbation of bronchial asthma
by: A P Rebrov, et al.
Published: (2004-03-01)

Long-Acting Bronchodilator Use in Chronic Obstructive Pulmonary Disease in Primary Care in New Zealand: A Retrospective Study of Treatment Patterns and Evolution Using the HealthStat Database
by: Milea D, et al.
Published: (2021-04-01)

The use of a standardized order set reduces systemic corticosteroid dose and length of stay for individuals hospitalized with acute exacerbations of COPD: a cohort study
by: Gulati S, et al.
Published: (2018-07-01)

COPD from an everyday primary care point of view
by: Antonio L Aguilar-Shea, et al.
Published: (2019-01-01)

Investigation serum procalcitonin in patients with exacerbation of obstructive pulmonary disease
by: Mina Delghandi, et al.
Published: (2020-12-01)

Effect of Monthly Vitamin D Supplementation on Preventing Exacerbations of Asthma or Chronic Obstructive Pulmonary Disease in Older Adults: Post Hoc Analysis of a Randomized Controlled Trial
by: Carlos A. Camargo, et al.
Published: (2021-02-01)

Cannot write session to /tmp/vufind_sessions/sess_4ka08g774l512m9rgs7n584qhu